Skip Navigation

AIDSinfo.nih.gov
AIDSinfo E-News:
Offering HIV/AIDS Research, Clinical Trials, Prevention, and Treatment Information.

AIDSinfo At-A-Glance

Volume Issue No. 2

February 25, 2005

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Information on Drug Toxicities

The AIDSinfo staff has compiled information on antiretroviral drug toxicities, including information from the Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, AIDSinfo Drug Database, and PubMed. Click here to read more.

Guidelines Updates

The Public Health Service Task Force "Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States" has been updated. All new information is highlighted in the document, which is available here. You can download the guidelines or request to receive them by e-mail or regular mail on the AIDSinfo Web site.

Coming soon: consumer-friendly fact sheets about mother-to-child transmission of HIV and how to prevent it.

FDA News

Dr. Lester M. Crawford Nominated to be FDA Commissioner: Read statement by Mike Leavitt, Secretary of Health and Human Services, regarding the nomination of Dr. Lester Crawford to be HHS communication.

FDA to Create New Drug Safety Oversight Board: February 15, 2005—HHS Secretary Mike Leavitt and Acting FDA Commissioner Lester M. Crawford unveiled a new emboldened vision for FDA that will promote a culture of openness and enhanced oversight within the Agency. As part of this vision, FDA will create a new independent Drug Safety Oversight Board to oversee the management of drug safety issues, and will provide emerging information to health care providers and patients about the risks and benefits of medicines. Click here to read more...

Research Info

Scientists map rare HIV antibody: U.S. researchers have mapped the structure of a rare human antibody that could neutralize the human immunodeficiency virus, the organism that causes AIDS. Click MedlinePlus for more information.  

Mouse "Model" of AIDS Mimics Human Disease: AIDS research has been hampered because mice, which usually provide an excellent model for studying human disease, cannot be infected with HIV. Now, researchers have created a modified HIV strain that can infect mice. Click here for more information.  

ClinicalTrials.gov Info

New HIV/AIDS trials have been added to ClinicalTrials.gov in the last 30 days. For a list of trials click here.

Please send comments or suggestions to ContactUs@aidsinfo.nih.gov




AIDSinfo Live Help "write-in" service

For individualized assistance with any questions regarding the guidelines or other HIV/AIDS-related research, clinical trials, and treatment, try our Live Help service at http://aidsinfo.nih.gov/live_help. This service provides real time, online assistance with a Health Information Specialist and is available Monday - Friday, 12:00 p.m. (Noon) - 4:00 p.m. Eastern Time.



You are currently subscribed to %%list.name%% as: %%emailaddr%%
To unsubscribe send a blank email to: %%email.unsub%%


For access to Federal HIV/AIDS information on clinical research, HIV treatment and prevention, and medical practice guidelines for health care providers and consumers, visit the AIDSinfo web site or
contact our information specialists via Live Help:   Monday - Friday, 12:00 p.m. (Noon) - 4:00 p.m. Eastern Time.

You may also contact our Help Line. English- and Spanish-speaking Health Information Specialists are available Monday - Friday, 12:00 p.m. (Noon) - 5:00 p.m. Eastern time.

Telephone: 800-448-0440
International: 301-519-0459
TTY/TDD: 888-480-3739

Download Adobe Acrobat® Reader™ to view PDF files located on this site.